Laviana Pharma
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese pharma company developing small molecule therapies for cancer and autoimmune diseases.
OncologyImmunology
Technology Platform
A small molecule drug discovery platform leveraging medicinal chemistry and target biology expertise to design novel kinase inhibitors and immunomodulators.
Opportunities
Potential to address specific, high-value targets in immuno-oncology or autoimmune diseases with oral small molecules.
Risk Factors
Risk of clinical failure or being outcompeted by similar molecules from larger companies with greater development speed and resources.
Competitive Landscape
Faces significant competition from global pharma giants and other biotechs in the crowded small molecule oncology and immunology spaces.